Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Bupivacaine hydrochloride, anhydrous
Noridem Enterprises Limited
N01BB01
Bupivacaine hydrochloride, anhydrous
2.5 milligram(s)/millilitre
Solution for injection
bupivacaine
Not marketed
2021-05-14
READ ALL OF THIS LEAFLET CAREFULLY BEFORE THIS MEDICINE IS GIVEN TO YOU BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4 WHAT IS IN THIS LEAFLET 1. What Bupivacaine is and what it is used for 2. What you need to know before Bupivacaine is given to you 3. How Bupivacaine is given 4. Possible side effects 5. How to store Bupivacaine 6. Contents of the pack and other information 1. WHAT BUPIVACAINE IS AND WHAT IT IS USED FOR Bupivacaine contains the active substance bupivacaine hydrochloride. It belongs to a group of medicines called amide-type local anaesthetics. This medicine is used to numb (anaesthetise) parts of the body. It is used to stop pain happening or to provide pain relief. It can be used to: • Numb parts of the body during surgery in adults and children above 12 years. • Relieve pain during childbirth. • Relieve pain in adults, infants and children above 1 year of age. 2. WHAT YOU NEED TO KNOW BEFORE BUPIVACAINE IS GIVEN TO YOU YOU MUST NOT BE GIVEN BUPIVACAINE • if you are allergic to bupivacaine hydrochloride or any of the other ingredients of this medicine (listed in section 6). • if you are allergic to any other local anaesthetics of the same class (such as lidocaine or ropivacaine). • if you have a skin infection near to where the injection will be given. • if you have something called cardiogenic shock (a condition where the heart is unable to supply enough blood to the body). • if you have something called hypovolaemic shock (very low blood pressure leading to collapse). • if you have problems with clotting of your blood (coagulation disorder) or ongoing anticoagulation treatment. • if you have diseases of the brain or spine such as meningitis, polio or spondylitis. • if you have a severe headache caused by bleeding in Read the complete document
Health Products Regulatory Authority 01 February 2022 CRN00CPQR Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Bupivacaine 2.5 mg / mL Solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL contains 2.5 mg bupivacaine hydrochloride anhydrous. Each 5-mL ampoule contains bupivacaine hydrochloride monohydrate equivalent to 12.5 mg bupivacaine hydrochloride anhydrous. Each 10-mL ampoule contains bupivacaine hydrochloride monohydrate equivalent to 25 mg bupivacaine hydrochloride anhydrous. Each 20-mL ampoule contains bupivacaine hydrochloride monohydrate equivalent to 50 mg bupivacaine hydrochloride anhydrous. Excipient with known effect: Each mL of Bupivacaine 2.5 mg / mL Solution contains 0.144 mmol (3.31 mg) of sodium. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, colourless solution. pH: 4.0-6.5 Osmolality: 270 – 320 mOsm/kg 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Bupivacaine is indicated for: Surgical anaesthesia in adults and children above 12 years of age Acute pain management in adults, infants and children above 1 year of age Bupivacaine is used for the production of prolonged local anaesthesia by percutaneous infiltration, intra-articular block, peripheral nerve block(s) and central neural block (caudal or epidural). Bupivacaine is also used for pain relief during labour. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dosage varies and depends upon the area to be anaesthetised, the vascularity of the tissues, the number of neuronal segments to be blocked, individual tolerance and the technique of anaesthesia used. Experience to date indicates a single dose of up to 150 mg bupivacaine hydrochloride. Doses of up to 50 mg 2-hourly may subsequently be used. A maximum dose of 2 mg / kg should not be exceeded in any four-hour period. Adults and children above 12 years of age The following table is a guide to dosage for the more commonly used techniques in the average adult. The Read the complete document